Recombinant Proteins Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2024 - 2030)

Get a Comprehensive Overview of the Recombinant Proteins Market Report Prepared by P&S Intelligence, Segmented by End User, Application, Product, and Geographic Regions. This Report Provides Insights From 2019 to 2030.

Report Code: 12527
Pages: 250

Chapter 1. Research Scope

1.1. Research Objectives

1.2. Market Definition

1.3. Analysis Period

1.4. Market Size Breakdown by Segments

1.4.1. Market size breakdown, by end user

1.4.2. Market size breakdown, by application

1.4.3. Market size breakdown, by product

1.4.4. Market size breakdown, by region

1.4.5. Market size breakdown, by country

1.5. Market Data Reporting Unit

1.5.1. Value

1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.1.1. Paid

2.1.2. Unpaid

2.1.3. P&S Intelligence database

2.2. Primary Research

2.3. Market Size Estimation

2.4. Data Triangulation

2.5. Currency Conversion Rates

2.6. Assumptions for the Study

2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Voice of Industry Experts/KOLs

Chapter 5. Market Indicators

Chapter 6. Industry Outlook

6.1. Market Dynamics

6.1.1. Trends

6.1.2. Drivers

6.1.3. Restraints/challenges

6.1.4. Impact analysis of drivers/restraints

6.2. Impact of COVID-19

6.3. Porter’s Five Forces Analysis

6.3.1. Bargaining power of buyers

6.3.2. Bargaining power of suppliers

6.3.3. Threat of new entrants

6.3.4. Intensity of rivalry

6.3.5. Threat of substitutes

Chapter 7. Global Market

7.1. Overview

7.2. Market Revenue, by End User (2019–2030)

7.3. Market Revenue, by Application (2019–2030)

7.3.1. Drug discovery & development market revenue, by application (2019–2030)

7.4. Market Revenue, by Product (2019–2030)

7.5. Market Revenue, by Region (2019–2030)

Chapter 8. North America Market

8.1. Overview

8.2. Market Revenue, by End User (2019–2030)

8.3. Market Revenue, by Application (2019–2030)

8.3.1. Drug discovery & development market revenue, by application (2019–2030)

8.4. Market Revenue, by Product (2019–2030)

8.5. Market Revenue, by Country (2019–2030)

Chapter 9. Europe Market

9.1. Overview

9.2. Market Revenue, by End User (2019–2030)

9.3. Market Revenue, by Application (2019–2030)

9.3.1. Drug discovery & development market revenue, by application (2019–2030)

9.4. Market Revenue, by Product (2019–2030)

9.5. Market Revenue, by Country (2019–2030)

Chapter 10. APAC Market

10.1. Overview

10.2. Market Revenue, by End User (2019–2030)

10.3. Market Revenue, by Application (2019–2030)

10.3.1. Drug discovery & development market revenue, by application (2019–2030)

10.4. Market Revenue, by Product (2019–2030)

10.5. Market Revenue, by Country (2019–2030)

Chapter 11. LATAM Market

11.1. Overview

11.2. Market Revenue, by End User (2019–2030)

11.3. Market Revenue, by Application (2019–2030)

11.3.1. Drug discovery & development market revenue, by application (2019–2030)

11.4. Market Revenue, by Product (2019–2030)

11.5. Market Revenue, by Country (2019–2030)

Chapter 12. MEA Market

12.1. Overview

12.2. Market Revenue, by End User (2019–2030)

12.3. Market Revenue, by Application (2019–2030)

12.3.1. Drug discovery & development market revenue, by application (2019–2030)

12.4. Market Revenue, by Product (2019–2030)

12.5. Market Revenue, by Country (2019–2030)

Chapter 13. U.S. Market

13.1. Overview

13.2. Market Revenue, by End User (2019–2030)

13.3. Market Revenue, by Application (2019–2030)

13.3.1. Drug discovery & development market revenue, by application (2019–2030)

13.4. Market Revenue, by Product (2019–2030)

Chapter 14. Canada Market

14.1. Overview

14.2. Market Revenue, by End User (2019–2030)

14.3. Market Revenue, by Application (2019–2030)

14.3.1. Drug discovery & development market revenue, by application (2019–2030)

14.4. Market Revenue, by Product (2019–2030)

Chapter 15. Germany Market

15.1. Overview

15.2. Market Revenue, by End User (2019–2030)

15.3. Market Revenue, by Application (2019–2030)

15.3.1. Drug discovery & development market revenue, by application (2019–2030)

15.4. Market Revenue, by Product (2019–2030)

Chapter 16. France Market

16.1. Overview

16.2. Market Revenue, by End User (2019–2030)

16.3. Market Revenue, by Application (2019–2030)

16.3.1. Drug discovery & development market revenue, by application (2019–2030)

16.4. Market Revenue, by Product (2019–2030)

Chapter 17. U.K. Market

17.1. Overview

17.2. Market Revenue, by End User (2019–2030)

17.3. Market Revenue, by Application (2019–2030)

17.3.1. Drug discovery & development market revenue, by application (2019–2030)

17.4. Market Revenue, by Product (2019–2030)

Chapter 18. Italy Market

18.1. Overview

18.2. Market Revenue, by End User (2019–2030)

18.3. Market Revenue, by Application (2019–2030)

18.3.1. Drug discovery & development market revenue, by application (2019–2030)

18.4. Market Revenue, by Product (2019–2030)

Chapter 19. Spain Market

19.1. Overview

19.2. Market Revenue, by End User (2019–2030)

19.3. Market Revenue, by Application (2019–2030)

19.3.1. Drug discovery & development market revenue, by application (2019–2030)

19.4. Market Revenue, by Product (2019–2030)

Chapter 20. Japan Market

20.1. Overview

20.2. Market Revenue, by End User (2019–2030)

20.3. Market Revenue, by Application (2019–2030)

20.3.1. Drug discovery & development market revenue, by application (2019–2030)

20.4. Market Revenue, by Product (2019–2030)

Chapter 21. China Market

21.1. Overview

21.2. Market Revenue, by End User (2019–2030)

21.3. Market Revenue, by Application (2019–2030)

21.3.1. Drug discovery & development market revenue, by application (2019–2030)

21.4. Market Revenue, by Product (2019–2030)

Chapter 22. India Market

22.1. Overview

22.2. Market Revenue, by End User (2019–2030)

22.3. Market Revenue, by Application (2019–2030)

22.3.1. Drug discovery & development market revenue, by application (2019–2030)

22.4. Market Revenue, by Product (2019–2030)

Chapter 23. Australia Market

23.1. Overview

23.2. Market Revenue, by End User (2019–2030)

23.3. Market Revenue, by Application (2019–2030)

23.3.1. Drug discovery & development market revenue, by application (2019–2030)

23.4. Market Revenue, by Product (2019–2030)

Chapter 24. South Korea Market

24.1. Overview

24.2. Market Revenue, by End User (2019–2030)

24.3. Market Revenue, by Application (2019–2030)

24.3.1. Drug discovery & development market revenue, by application (2019–2030)

24.4. Market Revenue, by Product (2019–2030)

Chapter 25. Brazil Market

25.1. Overview

25.2. Market Revenue, by End User (2019–2030)

25.3. Market Revenue, by Application (2019–2030)

25.3.1. Drug discovery & development market revenue, by application (2019–2030)

25.4. Market Revenue, by Product (2019–2030)

Chapter 26. Mexico Market

26.1. Overview

26.2. Market Revenue, by End User (2019–2030)

26.3. Market Revenue, by Application (2019–2030)

26.3.1. Drug discovery & development market revenue, by application (2019–2030)

26.4. Market Revenue, by Product (2019–2030)

Chapter 27. Saudi Arabia Market

27.1. Overview

27.2. Market Revenue, by End User (2019–2030)

27.3. Market Revenue, by Application (2019–2030)

27.3.1. Drug discovery & development market revenue, by application (2019–2030)

27.4. Market Revenue, by Product (2019–2030)

Chapter 28. South Africa Market

28.1. Overview

28.2. Market Revenue, by End User (2019–2030)

28.3. Market Revenue, by Application (2019–2030)

28.3.1. Drug discovery & development market revenue, by application (2019–2030)

28.4. Market Revenue, by Product (2019–2030)

Chapter 29. U.A.E. Market

29.1. Overview

29.2. Market Revenue, by End User (2019–2030)

29.3. Market Revenue, by Application (2019–2030)

29.3.1. Drug discovery & development market revenue, by application (2019–2030)

29.4. Market Revenue, by Product (2019–2030)

Chapter 30. Competitive Landscape

30.1. List of Market Players and their Offerings

30.2. Competitive Benchmarking of Key Players

30.3. Product Benchmarking of Key Players

30.4. Recent Strategic Developments

Chapter 31. Company Profiles

31.1. Thermo Fisher Scientific Inc.

31.1.1. Business overview

31.1.2. Product and service offerings

31.1.3. Key financial summary

31.2. Merck KGaA

31.2.1. Business overview

31.2.2. Product and service offerings

31.2.3. Key financial summary

31.3. Abcam plc

31.3.1. Business overview

31.3.2. Product and service offerings

31.3.3. Key financial summary

31.4. Bio-Rad Laboratories Inc.

31.4.1. Business overview

31.4.2. Product and service offerings

31.4.3. Key financial summary

31.5. Bio-Techne Corporation

31.5.1. Business overview

31.5.2. Product and service offerings

31.5.3. Key financial summary

31.6. Miltenyi Biotec B.V. & Co. KG

31.6.1. Business overview

31.6.2. Product and service offerings

31.7. ACROBiosystems

31.7.1. Business overview

31.7.2. Product and service offerings

31.8. RayBiotech Life Inc.

31.8.1. Business overview

31.8.2. Product and service offerings

31.9. Aviva Systems Biology Corporation

31.9.1. Business overview

31.9.2. Product and service offerings

31.10. Enzo Biochem Inc.

31.10.1. Business overview

31.10.2. Product and service offerings

31.10.3. Key financial summary

31.11. Sino Biological Inc.

31.11.1. Business overview

31.11.2. Product and service offerings

31.11.3. Key financial summary

31.12. BioLegend Inc.

31.12.1. Business overview

31.12.2. Product and service offerings

31.13. Synbio Technologies

31.13.1. Business overview

31.13.2. Product and service offerings

31.14. United States Biological

31.14.1. Business overview

31.14.2. Product and service offerings

31.15. StemCell Technologies Inc.

31.15.1. Business overview

31.15.2. Product and service offerings

Chapter 32. Appendix

32.1. Abbreviations

32.2. Sources and References

32.3. Related Reports

LIST OF TABLES

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 GLOBAL RECOMBINANT PROTEINS MARKET, BY END USER, $M (2017–2022)

TABLE 5 GLOBAL RECOMBINANT PROTEINS MARKET, BY END USER, $M (2023–2026)

TABLE 6 GLOBAL RECOMBINANT PROTEINS MARKET, BY END USER, $M (2027–2030)

TABLE 7 GLOBAL RECOMBINANT PROTEINS MARKET, BY APPLICATION, $M (2017–2022)

TABLE 8 GLOBAL RECOMBINANT PROTEINS MARKET, BY APPLICATION, $M (2023–2026)

TABLE 9 GLOBAL RECOMBINANT PROTEINS MARKET, BY APPLICATION, $M (2027–2030)

TABLE 10 GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET, BY APPLICATION, $M (2017–2022)

TABLE 11 GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET, BY APPLICATION, $M (2023–2026)

TABLE 12 GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET, BY APPLICATION, $M (2027–2030)

TABLE 13 GLOBAL RECOMBINANT PROTEINS MARKET, BY PRODUCT, $M (2017–2022)

TABLE 14 GLOBAL RECOMBINANT PROTEINS MARKET, BY PRODUCT, $M (2023–2026)

TABLE 15 GLOBAL RECOMBINANT PROTEINS MARKET, BY PRODUCT, $M (2027–2030)

TABLE 16 GLOBAL RECOMBINANT PROTEINS MARKET, BY REGION, $M (2017–2022)

TABLE 17 GLOBAL RECOMBINANT PROTEINS MARKET, BY REGION, $M (2023–2026)

TABLE 18 GLOBAL RECOMBINANT PROTEINS MARKET, BY REGION, $M (2027–2030)

TABLE 19 NORTH AMERICA RECOMBINANT PROTEINS MARKET, BY END USER, $M (2017–2022)

TABLE 20 NORTH AMERICA RECOMBINANT PROTEINS MARKET, BY END USER, $M (2023–2026)

TABLE 21 NORTH AMERICA RECOMBINANT PROTEINS MARKET, BY END USER, $M (2027–2030)

TABLE 22 NORTH AMERICA RECOMBINANT PROTEINS MARKET, BY APPLICATION, $M (2017–2022)

TABLE 23 NORTH AMERICA RECOMBINANT PROTEINS MARKET, BY APPLICATION, $M (2023–2026)

TABLE 24 NORTH AMERICA RECOMBINANT PROTEINS MARKET, BY APPLICATION, $M (2027–2030)

TABLE 25 NORTH AMERICA DRUG DISCOVERY & DEVELOPMENT MARKET, BY APPLICATION, $M (2017–2022)

TABLE 26 NORTH AMERICA DRUG DISCOVERY & DEVELOPMENT MARKET, BY APPLICATION, $M (2023–2026)

TABLE 27 NORTH AMERICA DRUG DISCOVERY & DEVELOPMENT MARKET, BY APPLICATION, $M (2027–2030)

TABLE 28 NORTH AMERICA RECOMBINANT PROTEINS MARKET, BY PRODUCT, $M (2017–2022)

TABLE 29 NORTH AMERICA RECOMBINANT PROTEINS MARKET, BY PRODUCT, $M (2023–2026)

TABLE 30 NORTH AMERICA RECOMBINANT PROTEINS MARKET, BY PRODUCT, $M (2027–2030)

TABLE 31 NORTH AMERICA RECOMBINANT PROTEINS MARKET, BY COUNTRY, $M (2017–2022)

TABLE 32 NORTH AMERICA RECOMBINANT PROTEINS MARKET, BY COUNTRY, $M (2023–2026)

TABLE 33 NORTH AMERICA RECOMBINANT PROTEINS MARKET, BY COUNTRY, $M (2027–2030)

TABLE 34 EUROPE RECOMBINANT PROTEINS MARKET, BY END USER, $M (2017–2022)

TABLE 35 EUROPE RECOMBINANT PROTEINS MARKET, BY END USER, $M (2023–2026)

TABLE 36 EUROPE RECOMBINANT PROTEINS MARKET, BY END USER, $M (2027–2030)

TABLE 37 EUROPE RECOMBINANT PROTEINS MARKET, BY APPLICATION, $M (2017–2022)

TABLE 38 EUROPE RECOMBINANT PROTEINS MARKET, BY APPLICATION, $M (2023–2026)

TABLE 39 EUROPE RECOMBINANT PROTEINS MARKET, BY APPLICATION, $M (2027–2030)

TABLE 40 EUROPE DRUG DISCOVERY & DEVELOPMENT MARKET, BY APPLICATION, $M (2017–2022)

TABLE 41 EUROPE DRUG DISCOVERY & DEVELOPMENT MARKET, BY APPLICATION, $M (2023–2026)

TABLE 42 EUROPE DRUG DISCOVERY & DEVELOPMENT MARKET, BY APPLICATION, $M (2027–2030)

TABLE 43 EUROPE RECOMBINANT PROTEINS MARKET, BY PRODUCT, $M (2017–2022)

TABLE 44 EUROPE RECOMBINANT PROTEINS MARKET, BY PRODUCT, $M (2023–2026)

TABLE 45 EUROPE RECOMBINANT PROTEINS MARKET, BY PRODUCT, $M (2027–2030)

Want a report tailored exactly to your business need?

Request Customization

Empowering Leaders Across the Globe

Leading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.

Client Testimonials

Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.

McKinsey & Company

India

Unmatched Standards

Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights

Complete Data Security

We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws

We use cookies to enhance your experience. By continuing to use this site you consent to our use of cookies. Privacy Policy X